Profiel
Marie-Eve Charrois is currently the Vice President-Regulatory Affairs at IMV, Inc. Prior to this, she worked as the Director-Regulatory Affairs at Medicago, Inc. and as the Manager-Site Conformance at GlaxoSmithKline Vaccines SRL.
She holds a graduate degree from Université Laval.
Actieve functies van Marie-Eve Charrois
Bedrijven | Functie | Begin |
---|---|---|
IMV INC. | Algemeen Adviseur | - |
Eerdere bekende functies van Marie-Eve Charrois
Bedrijven | Functie | Einde |
---|---|---|
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Algemeen Adviseur | - |
Glaxosmithkline Vaccines Srl
Glaxosmithkline Vaccines Srl BiotechnologyHealth Technology Glaxosmithkline Vaccines Srl engages in the development, production, and sale of biological preparations against infectious diseases. It offers vaccines for babies and children, teenagers and adults, travelers, and elderly people. The company was founded by Achille Sclavo in 1904 and is headquartered in Siena, Italy. | Corporate Officer/Principal | - |
Opleiding van Marie-Eve Charrois
Université Laval | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
IMV INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Glaxosmithkline Vaccines Srl
Glaxosmithkline Vaccines Srl BiotechnologyHealth Technology Glaxosmithkline Vaccines Srl engages in the development, production, and sale of biological preparations against infectious diseases. It offers vaccines for babies and children, teenagers and adults, travelers, and elderly people. The company was founded by Achille Sclavo in 1904 and is headquartered in Siena, Italy. | Health Technology |
Medicago, Inc.
Medicago, Inc. BiotechnologyHealth Technology Medicago, Inc. is a clinical-stage biopharmaceutical company. It develops novel vaccines and therapeutic proteins to address a broad range of infectious diseases worldwide. The firm provides vaccines and therapeutic proteins based on its proprietary Virus-Like Particles and manufacturing technologies. It develops Virus-Like Particles vaccines using a transient expression system which produces recombinant vaccine antigens in plants. The company was founded by Louis-Philippe Vézina on July 17, 1997 and is headquartered in Quebec, Canada. | Health Technology |